This week Dr. Martine Dehlinger-Kremer, vice president, scientific affairs, pediatric subject matter expert at ICON, joins us for a deep dive into the inclusion of adolescents in clinical trials. Martine talks us through the considerations for including adolescents in adult clinical trials and how to overcome potential challenges. She also highlights disease areas where the inclusion of adolescents in adult trials has proved successful and why she is optimistic for the future.
“Trial sponsors, investigators, regulators and ethics committees are encouraged to challenge research orthodoxy related to adolescent inclusion and adult research and seek trial solutions grounded in science rather than legal definition of age alone.”
Dr. Martine Dehlinger-Kremer is also chair of the Children's Medicines Working Party at the European Forum for Good Clinical Practice, as well as chair of the Pediatric Working Group of the European CRO Federation.